ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.31%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Depreciation & Amortization (CF) (2013 - 2026)

Updated

ProQR Therapeutics' Depreciation & Amortization (CF) came in at $821,790 for the quarter ended Jun 30, 2026, up 7.6% from $764,073 a year earlier and up 1.1% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, ProQR Therapeutics reported Depreciation & Amortization (CF) of $3.21 million, up 8.8% year-over-year; for the year ended Dec 31, 2025, it was $3.05 million, up 2.2% from the prior year.

  • Depreciation & Amortization (CF) has increased in each of the last three years, with a five-year compound annual growth rate of 2.6% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Depreciation & Amortization (CF) was $2.99 million in the year ended Dec 31, 2024 (+9.9%), $2.72 million in the year ended Dec 31, 2023 (+2.3%), $2.66 million in the year ended Dec 31, 2022 (-3.6%) and $2.76 million in the year ended Dec 31, 2021 (+2.5%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Depreciation & Amortization (CF) since the quarter ended Jun 30, 2018.
  • Year-over-year, Depreciation & Amortization (CF) has increased for four consecutive quarters, with growth averaging 3.7% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in the quarter ended Mar 31, 2024 (growth of 27.4%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 18.8%).
  • Business Quant data shows PRQR's Depreciation & Amortization (CF) at $812,497 (quarter ended Mar 31, 2026), $790,386 (quarter ended Dec 31, 2025) and $784,436 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 ProQR Therapeutics 171.74 Mn -291.86 Mn - 821,789.83
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 821,789.83
Mar 31, 2026 812,497.48
Dec 31, 2025 790,385.55
Sep 30, 2025 784,435.97
Jun 30, 2025 764,072.79
Mar 31, 2025 713,177.65
Dec 31, 2024 717,027.51
Sep 30, 2024 755,575.02
Jun 30, 2024 765,667.07
Mar 31, 2024 750,675.98
Dec 31, 2023 783,284.25
Sep 30, 2023 698,875.09
Jun 30, 2023 646,821.09
Mar 31, 2023 589,264.66
Dec 31, 2022 763,145.03
Sep 30, 2022 617,063.89
Jun 30, 2022 630,630.50
Mar 31, 2022 639,732.50
Dec 31, 2021 631,471.97
Sep 30, 2021 641,532.30
API Access

ProQR Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRQR&period=max&api_key=YOUR_API_KEY